World's Best Scientists 2026 revealed!
Federica Cavallo

Federica Cavallo

D-Index & Metrics

Biology and Biochemistry

D-Index
76
Citations
21094
World Ranking
5040
National Ranking
111

Medicine

D-Index
77
Citations
22228
World Ranking
18413
National Ranking
740

Overview

Federica Cavallo is affiliated with the University of Turin in Italy and has a significant academic presence mainly in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans key subfields including Immunology, Oncology, Molecular Biology, Genetics, and Pulmonary and Respiratory Medicine.

Their work covers several main topics, such as Immunotherapy and Immune Responses, Virus-based Gene Therapy Research, Cancer Immunotherapy and Biomarkers, Lymphoma Diagnosis and Treatment, Cancer Cells and Metastasis, Veterinary Oncology Research, and Immune Cells in Cancer.

Frequent coauthors contributing to their publications include Laura Conti, Federica Riccardo, Elisabetta Bolli, Elena Quaglino, and Lidia Tarone.

Federica Cavallo has published extensively in several journals, with notable frequent publication venues including Hematological Oncology, Blood, Cancers, Frontiers in Oncology, and the International Journal of Molecular Sciences.

Among their recent papers are:

  • "Evaluation of Bone Age in Children: A Mini-Review" (2021) published in Frontiers in Pediatrics
  • "The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy" (2021) published in Frontiers in Oncology
  • "Non-Melanoma Skin Cancers: Biological and Clinical Features" (2020) published in International Journal of Molecular Sciences
  • "Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy" (2021) published in mAbs
  • "Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota" (2020) published in International Journal of Molecular Sciences

Best Publications

  • A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction.

    Giuliana Pelicci;Luisa Lanfrancone;Francesco Grignani;Jane McGlade

  • Autologous transplantation and maintenance therapy in multiple myeloma

    Antonio Palumbo;Federica Cavallo;Francesco Di Raimondo

  • Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation.

    Ichiro Hanamura;James P. Stewart;James P. Stewart;Yongsheng Huang;Yongsheng Huang;Fenghuang Zhan;Fenghuang Zhan

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.

    Antonio Palumbo;Sara Bringhen;Anna M. Liberati;Tommaso Caravita

  • Vaccines for tumour prevention

    Pier-Luigi Lollini;Federica Cavallo;Patrizia Nanni;Guido Forni

  • Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

    Katia Boggio;Giordano Nicoletti;Emma Di Carlo;Federica Cavallo

  • 2011: the immune hallmarks of cancer

    Federica Cavallo;Carla De Giovanni;Patrizia Nanni;Guido Forni

  • Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial

    Antonio Palumbo;Sara Bringhen;Maria Teresa Petrucci;Pellegrino Musto

  • Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

    Alessandra Larocca;Pierre Wijermans;Federica Cavallo

  • Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma

    Marco Ladetto;Gloria Pagliano;Simone Ferrero;Federica Cavallo

  • Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

    Alessandra Larocca;Federica Cavallo;Sara Bringhen;Francesco Di Raimondo

  • Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

    Marta Coscia;Elena Quaglino;Manuela Iezzi;Claudia Curcio

  • Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

    Patrizia Nanni;Giordano Nicoletti;Carla De Giovanni;Lorena Landuzzi

  • Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

    Nagesh Kalakonda;Marie Maerevoet;Federica Cavallo;George Follows

  • Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.

    Alessandra Allione;Manuela Consalvo;Patrizia Nanni;Pier Luigi Lollini

  • Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.

    Federica Cavallo;Mirella Giovarelli;Alberto Gulino;Alessandra Vacca

  • Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.

    M Giovarelli;P Musiani;A Modesti;P Dellabona

  • Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma

    Antonio Palumbo;Maria Teresa Ambrosini;Giulia Benevolo;Patrizia Pregno

  • CYTOKINES, TUMOUR-CELL DEATH AND IMMUNOGENICITY : A QUESTION OF CHOICE

    Piero Musiani;Andrea Modesti;Mirella Giovarelli;Federica Cavallo

Frequent Co-Authors

Guido Forni
Guido Forni University of Turin
Mario Boccadoro
Mario Boccadoro University of Turin
Antonio Palumbo
Antonio Palumbo University of Turin
Piero Musiani
Piero Musiani University of Chieti-Pescara
Raffaele A. Calogero
Raffaele A. Calogero University of Turin
Pellegrino Musto
Pellegrino Musto University of Bari Aldo Moro
Mirella Giovarelli
Mirella Giovarelli University of Turin
Umberto Vitolo
Umberto Vitolo University of Turin
Patrizia Nanni
Patrizia Nanni University of Bologna
Paolo Corradini
Paolo Corradini University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens doors to many interdisciplinary career paths. Today, flexible education options make it easier to pursue specialized roles in healthcare, research, and nutrition—often without ever stepping foot on campus. Choosing the right online program is crucial. Cost, program length, and accreditation are key factors to consider.

For those interested in nutrition, an online dietitian degree can pave the way to roles such as licensed nutritionist or dietitian, while offering affordability and convenience. Registered nurses wishing to advance their qualifications can investigate rn to bsn online programs, which provide accelerated routes to higher credentials.

If your interests include healthcare leadership or administration, consider an accelerated healthcare management degree online, designed for busy professionals. Alternatively, students aiming to enter mental health nursing fields may explore accelerated msn psychiatric np programs to quickly gain specialized clinical skills.

These online pathways offer flexibility and targeted expertise—helping students seamlessly move from foundational science degrees to rewarding careers across the health and life sciences.

Best Scientists Citing Federica Cavallo

Trending Scientists

Recently Published Articles